Many groups are working to discover new, safer ways to deliver drugs that fight cancer to the tumor without damaging healthy cells. Others are finding ways to boost the body’s own immune system to attack cancer cells. For the first time, researchers at Penn State have combined the two approaches by conjugating biodegradable polymer nanoparticles encapsulated with chosen cancer-fighting drugs into immune cells to create a smart, targeted system to attack cancers of specific types.
“The traditional way to deliver drugs to tumors is to put the drug inside some type of nanoparticle and inject those particles into the bloodstream,” said Jian Yang, professor of biomedical engineering, Penn State. “Because the particles are so small, if they happen to reach the tumor site they have a chance of penetrating through the blood vessel wall because the vasculature of tumors is usually leaky.”
The odds of interacting with cancer cells can be improved by coating the outside of the nanoparticles with antibodies or certain proteins or peptides that will lock onto the cancer cell when they make contact. However, this is still a passive drug delivery technology. If the particle does not go to the tumor, there is no chance for them to bind and deliver the drug.
Yang and Cheng Dong, department head and distinguished professor of biomedical engineering, wanted a more active method of targeting drugs to the cancer wherever it was located, whether circulating in the blood, or in the brain or in any of the other organs of the body.
“I have 10 years of working in immunology and cancer,” Dong said. “Jian is more a biomaterials scientist. He knows how to make the nanoparticles biodegradable. He knows how to modify the particles with surface chemistry, to decorate them with peptides or antibodies. His material is naturally fluorescent, so you can track the particles at the same time they are delivering the drug, a process called theranostics that combines therapy and diagnostics. On the other hand, I study the cancer microenvironment, and I have discovered that the microenvironment of the tumor generates kinds of inflammatory signals similar to what would happen if you had an infection.”
Immune cells, which were built to respond to inflammatory signals, will be naturally attracted to the tumor site. This makes immune cells a perfect active delivery system for Yang’s nanoparticles. The same technology is also likely to be effective for infectious or other diseases, as well as for tissue regeneration, Dong said.
In the first proof of their technology, the two research groups targeted circulating melanoma cells. In a paper published in the current online issue of the journal Small, titled “Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting,” the researchers report the use of a novel biodegradable and photoluminescent poly (lactic acid) (BPLP-PLA) nanoparticle, loaded with melanoma-specific drugs with immune cells as the nanoparticle carriers. They showed that the immune cells could bind to the melanoma cells under shear stress conditions similar to those in the bloodstream. These experiments were all performed outside the body. Next they intend to perform studies in animal models and in solid tumors.
“This is the first study and is just to show that the technology works,” Dong said. “This study is not about curing melanoma. There are probably other ways to do that. We used melanoma cells to validate the approach.”
Learn more: New Technique Uses Immune Cells to Deliver Anti-Cancer Drugs
[osd_subscribe categories=’drug-delivery’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “DRUG DELIVERY”‘]
Receive an email update when we add a new DRUG DELIVERY article.
The Latest on: Nanoparticle drug delivery
[google_news title=”” keyword=”nanoparticle drug delivery” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Nanoparticle drug delivery
- Nanoparticle researchers develop microfluidic platform for better delivery of gene therapy for lung diseaseon May 7, 2024 at 7:14 am
Drug delivery researchers at Oregon State University have developed a device with the potential to improve gene therapy for patients with inherited lung diseases such as cystic fibrosis.
- Nanotechnology in Therapeuticson May 6, 2024 at 4:59 pm
Nanomedicine. 2012;7(8):1253-1271. Although passive targeting approaches form the basis of clinical therapy, they suffer from several limitations. Ubiquitously targeting cells within a tumor is ...
- Nanotechnology in Therapeuticson May 2, 2024 at 5:00 pm
Nanomedicine. 2012;7(8):1253-1271. Liposomes Liposomes are self-assembled artificial vesicles developed from amphiphilic phospholipids. These vesicles consist of a spherical bilayer structure ...
- Phosphorex and NOF CORPORATION Collaborate to Supply Lipid Nanoparticle Formulations using NOF's Proprietary Ionizable Lipid, COATSOME® SS Serieson April 30, 2024 at 6:24 am
Phosphorex, an Ampersand Capital Partners company and drug delivery-focused contract development and manufacturing organization ("CDMO"), announced today a collaboration with NOF CORPORATION to supply ...
- Penn bioengineering professor develops lipid nanoparticles to deliver mRNA inside human cellson April 29, 2024 at 12:47 am
Mitchell leads a biomaterials and drug delivery lab at Penn Engineering that works on engineering new biomaterials, such as lipid nanoparticles.
- Ultrasensitive photonic crystal detects single particles down to 50 nanometerson April 24, 2024 at 12:49 pm
Using an ultrasensitive photonic crystal, TU/e researchers were able to detect single particles down to 50 nanometers in diameter. The new research has just been published in the journal Optica.
- Revolutionising Nanoparticle Production: Technical Evaluation Introduces Cutting-Edge Formulation Technologyon April 18, 2024 at 5:00 pm
In a significant stride towards advancing nanoparticle drug delivery manufacturing technology, German pharmatech company, leon-nanodrugs GmbH (LEON), proudly announces a pioneering technical ...
- Polymeric Nanoparticles: Versatile Carriers for Drug Delivery and Beyondon April 10, 2024 at 9:19 am
The synthesis of polymeric nanoparticles involves various techniques, such as: Polymeric nanoparticles are extensively used as drug delivery vehicles for various therapeutic agents, such as small ...
- MIT’s metal-organic nanoparticles boost vaccine efficacy, deliveryon March 6, 2024 at 11:17 am
Nanoparticles are small ... “Understanding how the drug delivery vehicle can enhance an adjuvant immune response is something that could be very helpful in designing new vaccines,” says ...
via Bing News